Iovance Biotherapeutics, Inc.

Q2 2020 vs. Q4 2020 13F Holders

Period
Q2 2020
Q4 2020
Num holders
286
298
Total reported value, excl. options
$3.88 B
$6.91 B
Total shares, excl. options
140,892,901
148,963,930
Manager Q2 2020
Shares 		Q4 2020
Shares 		Diff Chg %